NCT06660394: A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
- State
- Under way
- Phase
- Phase 3
- People
- 108 taking part
- Started
- 25 Sep 2024
- Primary completion
- 31 Dec 2026
- Arms
- LP352
- Results
- None posted
- 25 Sep 2024: Trial started
- 28 Oct 2024: Trial registered